Towards Agility in Breast Cancer Treatment Principles as Adopted from Agile Software Engineering

References

• World Health Organization. 2023 Breast Cancer. Available From: https://www.who.int/news-room/fact-sheets/detail/breast-cancer. Accessed July 23, 2023.
   Google Scholar
• Olopade OI, Grushko TA, Nanda R, Huo D. Advances in breast cancer: pathways to personalized medicine. Clin Cancer Res. 2008;14:7988–7999. doi:10.1158/1078-0432.CCR-08-1211
   PubMed Web of Science ®Google Scholar
• Sarhangi N, Hajjari S, Heydari SF, Ganjizadeh M, Rouhollah F, Hasanzad M. Breast cancer in the era of precision medicine. Molec Biol Rep. 2022;49:10023–10037. doi:10.1007/s11033-022-07571-2
   PubMedGoogle Scholar
• Segota E, Bukowski RM. The promise of targeted therapy: cancer drugs become more specific. Cleve Clin J Med. 2004;71:551–560. doi:10.3949/ccjm.71.7.551
   PubMed Web of Science ®Google Scholar
• Gambardella V, Tarazona N, Cejalvo JM, et al. Personalized medicine: recent progress in cancer therapy. Cancers. 2020;12:1009. doi:10.3390/cancers12041009
   PubMed Web of Science ®Google Scholar
• Khoury T. The evolving approach to breast cancer: moving toward de-escalating treatment and personalized. Cancers. 2023;15:3502. doi:10.3390/cancers15133502
   PubMed Web of Science ®Google Scholar
• Rodrigues R, Duarte D, Vale N. Drug repurposing in cancer therapy: influence of patient’s genetic background in breast cancer treatment. Int J Mol Sci. 2022;23:4280. doi:10.3390/ijms23084280
   PubMed Web of Science ®Google Scholar
• Uiterkamp AJMS, Vlek C. Practice and outcomes of multidisciplinary research for environmental sustainability. Journal of Social Issues. 2007;63:175–197. doi:10.1111/j.1540-4560.2007.00502.x
   Web of Science ®Google Scholar
• Sommerville I. Software Engineering. 10th ed. Pearson: India; 2017.
   Google Scholar
• Beck K, Beedle M, van Bennekum A, et al. Agile Manifesto; 2022. Available from: https://www.agilealliance.org/agile101/the-agile-manifesto/. Accessed July 19, 2023.
   Google Scholar
• Highsmith J, Cockburn A. Agile software development: the business of innovation. Computer. 2001;34:120–127. doi:10.1109/2.947100
   Web of Science ®Google Scholar
• Fowler M. The Agile Manifesto: where it came from and where it may go; 2002. Available from: http://martinfowler.com/articles/agileStory.html. Accessed July 15, 2023.
   Google Scholar
• Zaina LAM, Sharp H, Barroca L. UX information in the daily work of an agile team: a distributed cognition analysis. Int J Hum Comput Stud. 2021;147:102574. doi:10.1016/j.ijhcs.2020.102574
   Web of Science ®Google Scholar
• Sindhwani R, Singh PL, Prajapati DK, Iqbal A, Phanden RK, Malhotra V. Agile System in Health Care: literature Review. Advan Indust Prod Eng. 2019;1:643–652.
   Google Scholar
• Kokol P, Blažun H, Kokol M, Završnik J. Role of agile in digital public health transformation. Front Public Health. 2022;10:1111. doi:10.3389/fpubh.2022.899874
   Google Scholar
• Ivanova D, Kadurin V. A New Proposed Software Development Methodology for Healthcare Industry. In: Proceedings of the 46th International Conference Applications of Mathematics in Engineering and Economics. Sofia, Bulgaria; 2020.
   Google Scholar
• Goodison R, Borycki EM, Kushniruk AW. Use of agile project methodology in health care IT implementations: a scoping review. Stud Health Technol Inform. 2019;257:140–145.
   PubMedGoogle Scholar
• Thomas A, Suresh M. Readiness for agility adaptability and alignment in healthcare organizations. IISE Trans Healthc Syst Eng. 2023;13(2):161–174. doi:10.1080/24725579.2022.2144966
   Google Scholar
• Chen WS, Leung CY, Kamath JRC. Advancing change agility in healthcare. Manag Healthcare. 2023;7(2):102–111.
   Google Scholar
• Broekharst DS, van de Wetering R, Ooms W, Helms RW, Roijakkers N. Deploying predictive analytics to enhance patient agility and patient value in hospitals: a position paper and research proposal. Health Anal. 2023;3:100141. doi:10.1016/j.health.2023.100141
   Google Scholar
• Balogh E, Ganz P, Murphy S, Nass S, Ferrell B, Stovall E. Patient‐centered cancer treatment planning: improving the quality of oncology care. Summary of an institute of medicine workshop. Oncologist. 2011;16:1800–1805. doi:10.1634/theoncologist.2011-0252
   PubMed Web of Science ®Google Scholar
• Malik JA, Ahmed S, Jan B, et al. Drugs repurposed: an advanced step towards the treatment of breast cancer and associated challenges. Bio Pharmac. 2022;145:112375. doi:10.1016/j.biopha.2021.112375
   Google Scholar
• Taefehshokr S, Parhizkar A, Hayati S, et al. Cancer immunotherapy: challenges and limitations. Pathol Res Pract. 2022;229:153723. doi:10.1016/j.prp.2021.153723
   PubMed Web of Science ®Google Scholar
• Schot E, Tummers L, Noordegraaf M. Working on working together: a systematic review on how healthcare professionals contribute to inter-professional collaboration. J Interprof Care. 2020;34:332–342. doi:10.1080/13561820.2019.1636007
   PubMed Web of Science ®Google Scholar
• Katz SJ, Belkora J, Elwyn G. Shared decision making for treatment of cancer: challenges and opportunities. J Oncol Pract. 2014;10:206–208. doi:10.1200/JOP.2014.001434
   PubMedGoogle Scholar
• Maes-Carballo M, Martín-Díaz M, Mignini L, Khan KS, Trigueros R, Bueno-Cavanillas A. Evaluation of the use of shared decision making in breast cancer: international survey. Int J Environ Res Public Health. 2021;18:2128. doi:10.3390/ijerph18042128
   PubMed Web of Science ®Google Scholar
• Nardin S, Mora E, Varughese FM, et al. Breast cancer survivorship, quality of life, and late toxicities. Front Oncol. 2020;10:864. doi:10.3389/fonc.2020.00864
   PubMed Web of Science ®Google Scholar
• Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108:2205–2240. doi:10.1038/bjc.2013.177
   PubMed Web of Science ®Google Scholar
• Gennari A, D’amico M, Corradengo D. Extending the duration of first-line chemotherapy in metastatic breast cancer: a perspective review. Therapeut Adv Med Oncol. 2011;3:229–232. doi:10.1177/1758834011413423
   PubMedGoogle Scholar
• Basu P, Tripathi R, Mehrotra R, Ray K, Srivastava A, Srivastava A. Role of integrative medicine in the continuum of care of breast cancer patients in the Indian context. Cancer Causes Control. 2021;32:429–440. doi:10.1007/s10552-021-01399-0
   PubMed Web of Science ®Google Scholar
• Hudis CA, Gianni L. Triple‐negative breast cancer: an unmet medical need. Oncologist. 2011;16:1–11. doi:10.1634/theoncologist.2011-S1-01
   PubMed Web of Science ®Google Scholar
• Bleicher RJ, Ruth K, Sigurdson ER, et al. Time To surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2:330–339. doi:10.1001/jamaoncol.2015.4508
   PubMed Web of Science ®Google Scholar
• Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A. Adherence To Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer. J Clin oncol. 2008;26:556–562. doi:10.1200/JCO.2007.11.5451
   PubMed Web of Science ®Google Scholar
• McLaughlin R, Hylton N. MRI In Breast Cancer Therapy Monitoring. NMR Biomed. 2011;24:712–720. doi:10.1002/nbm.1739
   PubMed Web of Science ®Google Scholar
• Duygulu G, Oktay A, Bilgen IG, Kapkaç M, Zekioğlu O. The role of breast MRI in planning the surgical treatment of breast cancer. Diagn Interv Radiol. 2012;18:460–467. doi:10.4261/1305-3825.DIR.5429-11.2
   PubMed Web of Science ®Google Scholar
• Christensen D, Shehata M, Javid S, Rahbar H, Lam D. Preoperative breast MRI: current evidence and patient selection. J Br Imag. 2023;5:112–124. doi:10.1093/jbi/wbac088
   PubMedGoogle Scholar
• Schauer T, Henriksson A, Strandberg E, et al. Pre-treatment levels of inflammatory markers and chemotherapy completion rates in patients with early-stage breast cancer. Internat J Clin Oncol. 2023;28:89–98. doi:10.1007/s10147-022-02255-0
   PubMed Web of Science ®Google Scholar
• Groen WG, Naaktgeboren WR, Van Harten WH, et al. Physical fitness and chemotherapy tolerance in patients with early-stage breast cancer. Med Sci Sport Exer. 2022;54:537–542. doi:10.1249/MSS.0000000000002828
   PubMed Web of Science ®Google Scholar
• Buda-Nowak A, Kwinta Ł, Potocki P, et al. Metronomic chemo-endocrine therapy (FulVEC) as a salvage treatment for patients with advanced, treatment-refractory ER+/HER2-breast cancer—a retrospective analysis of consecutive patients data. J Clin Med. 2023;12:1350. doi:10.3390/jcm12041350
   PubMed Web of Science ®Google Scholar
• Bonilla L, Ben-Aharon I, Vidal L, Gafter-Gvili A, Leibovici L, Stemmer SM. Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials. J National Cancer Inst. 2010;102:1845–1854. doi:10.1093/jnci/djq409
   PubMed Web of Science ®Google Scholar
• Chikermane SG, Sharma M, Abughosh SM, Aparasu RR, Trivedi MV, Johnson ML. Dose-dependent relation between metformin and the risk of hormone receptor-positive, Her2-negative breast cancer among postmenopausal women with type-2 diabetes. Br Can Res Treat. 2022;195:421–430. doi:10.1007/s10549-022-06706-0
   PubMed Web of Science ®Google Scholar
• Ben-Ari E. Shorter course of radiation is effective, safe for some with early-stage breast cancer; 2022. Available from: https://www.cancer.gov/news-events/cancer-currents-blog/2022/early-breast-cancer-shorter-radiation-therapy. Accessed July 23, 2023.
   Google Scholar
• Jones B, Green S. Modern radiation techniques in early stage breast cancer for the breast radiologist. Clin Imaging. 2021;80:19–25. doi:10.1016/j.clinimag.2021.06.035
   PubMed Web of Science ®Google Scholar
• Nassif AB, Talib MA, Nasir Q, Afadar Y, Elgendy O. Breast Cancer Detection Using Artificial Intelligence Techniques: a Systematic Literature Review. Artif. Intell. Med. 2022;127:102276. doi:10.1016/j.artmed.2022.102276
   PubMed Web of Science ®Google Scholar
• Yusoff M, Haryanto T, Suhartanto H, Mustafa WA, Zain JM, Kusmardi K. Accuracy analysis of deep learning methods in breast cancer classification: a structured review. Diagnostics. 2023;13:683. doi:10.3390/diagnostics13040683
   Web of Science ®Google Scholar
• Chopra S, Khosla M, Vidya R. Innovations and challenges in breast cancer care: a review. Medicina. 2023;59:957. doi:10.3390/medicina59050957
   PubMedGoogle Scholar
• Sabih QA, Lupinacci KM, Diego EJ. Current recommendations and role of breast conservation surgery for multifocal or multicentric breast cancer. Curr Br Can Rep. 2023;1:1–9.
   Google Scholar
• Sabatier R, Gonçalves A, Bertucci F. Personalized medicine: present and future of breast cancer management. Crit Rev Oncol/Hematol. 2014;91:223–233. doi:10.1016/j.critrevonc.2014.03.002
   PubMed Web of Science ®Google Scholar
• Jun Z, Yu X, Xiaomei Z, et al. Current landscape of personalized clinical treatments for triple-negative breast cancer. Front Pharmacol. 2022;13:1.
   Web of Science ®Google Scholar
• Ahmed KA, Grass GD, Orman AG, et al. Personalizing radiation treatment delivery in the management of breast cancer. Internat J Br Can. 2018;2018. doi:10.1155/2018/6729802
   Google Scholar
• Condorelli R, Vaz-Luis I. Managing side effects in adjuvant endocrine therapy for breast cancer. Expert Rev Anticancer Ther. 2018;18:1101–1112. doi:10.1080/14737140.2018.1520096
   PubMed Web of Science ®Google Scholar
• Odle TG. Adverse effects of breast cancer treatment. Radiol Technol. 2014;85:297M–319M.
   PubMedGoogle Scholar
• Palesh O, Scheiber C, Kesler S, Mustian K, Koopman C, Schapira L. Management of side effects during and post‐treatment in breast cancer survivors. Br J. 2018;24:167–175. doi:10.1111/tbj.12862
   Google Scholar
• Wanchai A, Anderson EA, Armer JM. A systematic review of m-health apps on managing side effects of breast cancer treatment. Support Care Cancer. 2023;31:86. doi:10.1007/s00520-022-07464-x
   Web of Science ®Google Scholar
• Dear RF, McGeechan K, Jenkins MC, Barratt A, Tattersall MH, Wilcken N. combination versus sequential single agent chemotherapy for metastatic breast cancer. Cochrane Database Syst Rev. 2013;12:1.
   Google Scholar
• Carrick S, Parker S, Thornton C, Ghersi D, Simes J, Wilcken N. Single agent versus combination chemotherapy for metastatic breast cancer. Cochrane Database Syst Rev. 2009;2:1.
   Google Scholar
• Van Wyhe RD, Rahal OM, Woodward WA. Effect of statins on breast cancer recurrence and mortality: a review. Br Can. 2017;1:559–565.
   Google Scholar
• Blank PR, Dedes KJ, Szucs TD. Cost effectiveness of cytotoxic and targeted therapy for metastatic breast cancer. Pharmacoeconomics. 2010;28:629–647. doi:10.2165/11535560-000000000-00000
   PubMed Web of Science ®Google Scholar
• Mann RM, Athanasiou A, Baltzer PAT, et al. Breast cancer screening in women with extremely dense breasts recommendations of the European society of breast imaging (EUSOBI). Eur Radiol. 2022;32:4036–4045. doi:10.1007/s00330-022-08617-6
   PubMed Web of Science ®Google Scholar
• Offersen BV, Alsner J, Nielsen HM, et al. Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized Phase III trial: the DBCG HYPO Trial. J Clin oncol. 2020;38:3615–3625. doi:10.1200/JCO.20.01363
   PubMed Web of Science ®Google Scholar
• Cancer Council Australia. Optimal care pathway for people with breast cancer: quick reference guide; 2021. Available from: https://www.cancer.org.au/assets/pdf/breast-cancer-quick-reference-guide. Accessed July 23, 2023.
   Google Scholar
• Aitken LA, Hossan SZ. The psychological distress and quality of life of breast cancer survivors in Sydney, Australia. In Healthcare. 2022;2017:10.
   Google Scholar
• Henry DH, Viswanathan HN, Elkin EP, Traina S, Wade S, Cella D. Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the US. Support Care Cancer. 2008;16:791–801. doi:10.1007/s00520-007-0380-2
   PubMed Web of Science ®Google Scholar
• Perry LM, Hoerger M, Seibert K, Gerhart JI, O’Mahony S, Duberstein PR. Financial strain and physical and emotional quality of life in breast cancer. J Pain Sympt Manage. 2019;58:454–459. doi:10.1016/j.jpainsymman.2019.05.011
   PubMed Web of Science ®Google Scholar
• Spence D, Morstyn L, Wells K. The support and information needs of women with secondary breast cancer (Breast Cancer Network Australia); 2015. Available from: https://www.bcna.org.au/media/2936/bcn1166-sbc-report-2015.pdf. Accessed July 23, 2023.
   Google Scholar
• Mehnert A. Employment And Work-Related Issues In Cancer Survivors. Crit Rev Oncol Hematol. 2011;77:109–130. doi:10.1016/j.critrevonc.2010.01.004
   PubMed Web of Science ®Google Scholar
• Schmidt ME, Scherer S, Wiskemann J, Steindorf K. Return to work after breast cancer: the role of treatment‐related side effects and potential impact on quality of life. European Journal of Cancer Care. 2019;28:e13051. doi:10.1111/ecc.13051
   PubMed Web of Science ®Google Scholar
• Al-Rashdan A, Roumeliotis M, Quirk S, et al. Adapting radiation therapy treatments for patients with breast cancer during the COVID-19 pandemic: hypo-fractionation and accelerated partial breast irradiation to Address world health organization recommendations. Adv Radiat Oncol. 2020;5:575–576. doi:10.1016/j.adro.2020.03.011
   PubMedGoogle Scholar
• Li L, Chang B, Jiang X, et al. Clinical outcomes comparison of 10 years versus 5 years of adjuvant endocrine therapy in patients with early breast cancer. BMC Cancer. 2018;18:1–11. doi:10.1186/s12885-018-4878-4
   PubMed Web of Science ®Google Scholar
• Wolff JL, Aufill J, Echavarria D, et al. A randomized intervention involving family to improve communication in breast cancer care. NPJ Breast Cancer. 2021;14.
   Google Scholar
• National Health Service (NHS). Information sharing in multidisciplinary teams (MDTs); 2022. Available from: https://transform.england.nhs.uk/information-governance/guidance/information-governance-guidance-support-multidisciplinary-teams-mdts/. Accessed July 18, 2023.
   Google Scholar
• Miller R. Implementing a survivorship care plan. Clin J Oncol Nurs. 2007;12:759–767.
   Web of Science ®Google Scholar
• Houserková D, Zlámalová N, Spáčilová K, et al. Role of the radiologist during neoadjuvant systemic therapy for breast cancer. Rozhl Chir. 2021;100:285–294. doi:10.33699/PIS.2021.100.6.285-294
   PubMedGoogle Scholar
• Carroll-Johnson R. Redefining interdisciplinary practice. Oncol nurs forum. 2001;28:619.
   PubMedGoogle Scholar
• Hewitt M, Greenfield S, Stovall E. Institute of Medicine & National Research Council (IOM & NRC). In: From Cancer Patient to Cancer Survivor: Lost in Transition. Washingon, DC: National Academies Press; 2006.
   Google Scholar
• Taylor C, Shewbridge A, Harris J, Green JS. Benefits of multidisciplinary teamwork in the management of breast cancer. Breast Cancer. 2013;30:79–85.
   Google Scholar
• Spalluto L, Bonnet K, Sonubi C, et al. Barriers to implementation of breast cancer risk assessment: the health care team perspective. J Am College Radiol. 2023;20:342–351.
   PubMed Web of Science ®Google Scholar
• Kesson EM, Allardice GM, George WD, Burns HJG, Morrison DS. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13,722 women. BMJ. 2012;344:e2718. doi:10.1136/bmj.e2718
   PubMed Web of Science ®Google Scholar
• Pangarsa EA, Rizky D, Tandarto K, et al. The effect of multidisciplinary team on survival rates of women with breast cancer: a systematic review and meta-analysis. Ann Med Surg Lond. 2023;85:2940–2948. doi:10.1097/MS9.0000000000000914
   PubMed Web of Science ®Google Scholar
• Kurniasih DAA, Setiawati EP, Pradipta IS, Subarnas A. Interprofessional collaboration in the breast cancer unit: how do healthcare workers see it? BMC Womens Health. 2022;22:1–9. doi:10.1186/s12905-022-01818-7
   PubMed Web of Science ®Google Scholar
• Van Veenendaal H, Voogdt-Pruis HR, Ubbink DT, Hilders CGJM. Effect of a multilevel implementation programme on shared decision-making in breast cancer care. BJS Open. 2021;5:zraa002. doi:10.1093/bjsopen/zraa002
   PubMed Web of Science ®Google Scholar
• Singleton AC, Raeside R, Hyun KK, et al. electronic health interventions for patients with breast cancer: systematic review and meta-analyses. J Clin Oncol. 2022;40:2257.
   PubMed Web of Science ®Google Scholar
• Khoshnazar TAK, Rassouli M, Akbari ME, et al. Communication needs of patients with breast cancer: a qualitative study. Indian J Palliat Care. 2016;22:402. doi:10.4103/0973-1075.191763
   PubMedGoogle Scholar
• Di Giacomo D, Ranieri J, Donatucci E, et al. Emotional “patient-oriented” support in young patients with i–ii stage breast cancer: pilot study. Front Psychol. 2018;9:2487. doi:10.3389/fpsyg.2018.02487
   PubMedGoogle Scholar
• Van de Water LF, Van Kleef JJ, Dijksterhuis WPM, et al. Communicating treatment risks and benefits to cancer patients: a systematic review of communication methods. Qual Life Res. 2020;29:1747–1766. doi:10.1007/s11136-020-02503-8
   PubMed Web of Science ®Google Scholar
• Sebri V, Durosini I, Mazzoni D, Pravettoni G. Breast cancer survivors’ motivation to participate in a tailored physical and psychological intervention: a qualitative thematic analysis. Behav Sci. 2022;12:271. doi:10.3390/bs12080271
   PubMedGoogle Scholar
• Luleci D, Kilic B. Factors affecting women’s participation in breast cancer screening in Turkey. Asian Pac J Cancer Prev. 2022;23:1627. doi:10.31557/APJCP.2022.23.5.1627
   PubMedGoogle Scholar
• Durosini I, Savioni L, Triberti S, Guiddi P, Pravettoni G. The motivation journey: a grounded theory study on female cancer survivors’ experience of a psychological intervention for quality of life. Int J Environ Res Public Health. 2021;18:950. doi:10.3390/ijerph18030950
   PubMed Web of Science ®Google Scholar
• Coletta AM, Basen-Engquist KM, Schmitz KH. Exercise across the cancer care continuum: why it matters, how to implement it, and motivating patients to move. Am Soc Clin Oncol Educat Book. 2022;42:932–938. doi:10.1200/EDBK_349635
   Google Scholar
• Porro B, Campone M, Moreau P, Roquelaure Y. Supporting the return to work of breast cancer survivors: from a theoretical to a clinical perspective. Int J Environ Res Public Health. 2022;19:5124. doi:10.3390/ijerph19095124
   PubMed Web of Science ®Google Scholar
• Karim UN, Setiyadi A, Efrida Y. Family support on motivation of compliance and chemotherapy protocol among patients with breast cancer. J Holis Nurs Sci. 2023;10:22–26. doi:10.31603/nursing.v0i0.7792
   Google Scholar
• Aprilianto E, Lumadi SA, Handian FI. Family social support and the self-esteem of breast cancer patients undergoing neoadjuvant chemotherapy. J Publ Health Res. 2021;10:jphr–2021. doi:10.4081/jphr.2021.2234
   Web of Science ®Google Scholar
• Kusi G, Boamah Mensah AB, Boamah Mensah K, Dzomeku VM, Apiribu F, Duodu PA. Caregiving motivations and experiences among family caregivers of patients living with advanced breast cancer in Ghana. PLoS One. 2020;15:e0229683. doi:10.1371/journal.pone.0229683
   PubMed Web of Science ®Google Scholar
• Kočo L, Weekenstroo HH, Lambregts DM, et al. The effects of multidisciplinary team meetings on clinical practice for colorectal, lung, prostate and breast cancer: a systematic review. Cancers. 2021;13:4159. doi:10.3390/cancers13164159
   PubMed Web of Science ®Google Scholar
• Barrios H. Global challenges in breast cancer detection and treatment. Breast. 2022;62:S3–S6. doi:10.1016/j.breast.2022.02.003
   PubMed Web of Science ®Google Scholar
• Ebben KC, Hendriks MP, Markus L, et al. Using guideline-based clinical decision support in oncological multidisciplinary team meetings: a prospective, multicenter concordance study. Int J Qual Health Care. 2022;34:mzac007. doi:10.1093/intqhc/mzac007
   PubMed Web of Science ®Google Scholar
• Freeman ALJ. How To communicate evidence to patients. Drug Therap Bulletin. 2019;57:119–124. doi:10.1136/dtb.2019.000008
   PubMedGoogle Scholar
• Ancker JS, Senathirajah Y, Kukafka R, Starren JB. Design features of graphs in health risk communication: a systematic review. J Am Med Inf Assoc. 2006;13:608–618. doi:10.1197/jamia.M2115
   PubMed Web of Science ®Google Scholar
• Shim EJ, Park J, Yi M, Jung D, Lee KM, Hahm BJ. Tailoring communications to the evolving needs of patients throughout the cancer care trajectory: a qualitative exploration with breast cancer patients. BMC Women’s Health. 2016;16:65. doi:10.1186/s12905-016-0347-x
   PubMed Web of Science ®Google Scholar
• Bruce JG, Tucholka JL, Steffens NM, Neuman HB. Quality of online information to support patient decision‐making in breast cancer surgery. J Surg Oncol. 2015;112:575–580. doi:10.1002/jso.24046
   PubMed Web of Science ®Google Scholar
• Conroy M, Powell M, Suelzer E, et al. Electronic medical record–based electronic messaging among patients with breast cancer: a systematic review. Appl Clin Inform. 2023;14:134–143. doi:10.1055/a-2004-6669
   PubMed Web of Science ®Google Scholar
• Huang Y, Li Q, Zhou F, Song J. Effectiveness of internet-based support interventions on patients with breast cancer: a systematic review and narrative synthesis. BMJ open. 2022;12:e057664. doi:10.1136/bmjopen-2021-057664
   PubMedGoogle Scholar
• Høybye MT, Johansen C, Tjørnhøj-Thomsen T. Online Interaction. Effects of storytelling in an internet breast cancer support group. Psycho-Oncology. 2005;14:211–220. doi:10.1002/pon.837
   PubMed Web of Science ®Google Scholar
• Orgad S. Storytelling Online: Talking Breast Cancer on the Internet. New York. USA: Peter Lang Publishing; 2005.
   Google Scholar
• Hong YA, Hossain MM, Chou WYS. Digital interventions to facilitate patient‐provider communication in cancer care: a systematic review. Psycho Oncol. 2020;29:591–603. doi:10.1002/pon.5310
   PubMed Web of Science ®Google Scholar
• Triberti S, Savioni L, Sebri V, Pravettoni G. Ehealth for improving quality of life in breast cancer patients: a systematic review. Cancer Treat Rev. 2019;74:1–14. doi:10.1016/j.ctrv.2019.01.003
   PubMed Web of Science ®Google Scholar
• Bender JL, Katz J, Ferris LE, Jadad AR. What is the role of online support from the perspective of facilitators of face-to-face support groups? A multi-method study of the use of breast cancer online communities. Pat Educat Couns. 2013;93:472–479. doi:10.1016/j.pec.2013.07.009
   PubMed Web of Science ®Google Scholar
• Setoyama Y, Yamazaki Y, Nakayama K. Comparing support to breast cancer patients from online communities and face-to-face support groups. Pat Educ Couns. 2011;85:e95–e100. doi:10.1016/j.pec.2010.11.008
   PubMed Web of Science ®Google Scholar
• Mayor S. Five year survival rate of women whose cancer is detected by screening has risen to 96.4%. BMJ. 2008;336:1398–1399. doi:10.1136/bmj.a373
   PubMedGoogle Scholar
• The Australian Institute of Health and Welfare. Breast cancer survival very high with early detection; 2007. Available from: https://www.aihw.gov.au/news-media/media-releases/2007/oct/breast-cancer-survival-very-high-with-early-detect. Accessed August 5, 2023.
   Google Scholar
• Office on Women Health (OWH). 99% percent survival rate for breast cancer caught early; 2022. Available from: https://www.womenshealth.gov/blog/99-percent-survival-rate-breast-cancer-caught-early. Accessed August 5, 2023.
   Google Scholar
• Edib Z, Kumarasamy V, Binti Abdullah N, Rizal AM, Al-Dubai SAR. Most prevalent unmet supportive care needs and quality of life of breast cancer patients in a tertiary hospital in Malaysia. Health Qual Life Outc. 2016;14:1–10. doi:10.1186/s12955-016-0428-4
   PubMed Web of Science ®Google Scholar
• Scharl A, Kühn T, Papathemelis T, Salterberg A. The right treatment for the right patient–personalised treatment of breast cancer. Geburtshilfe Frauenheilkd. 2015;75:683–691. doi:10.1055/s-0035-1546270
   PubMed Web of Science ®Google Scholar
• Selvan P, Hriso C, Mitchell J, Newberg A. Systematic review of yoga for symptom management during conventional treatment of breast cancer patients. Complement Therap Clin Pract. 2022;48. doi:10.1016/j.ctcp.2022.101581
   PubMed Web of Science ®Google Scholar
• Al-Hosni K, Chan MF, Al-Azri M. Effectiveness of an educational program on awareness of breast cancer risk factors, symptoms, and barriers to seeking medical help among adolescent Omani school students—an interventional study. Current Oncol. 2023;30:4126–4138. doi:10.3390/curroncol30040314
   PubMed Web of Science ®Google Scholar
• Rakhshani T, Dada M, Kashfi SM, Kamyab A, Jeihooni AK. The effect of educational intervention on knowledge, attitude, and practice of women towards breast cancer screening. Internat J Br Can. 2022;2022. doi:10.1155/2022/5697739
   Google Scholar
• Sisler J, Chaput G, Sussman J, Ozokwelu E. Follow-up after treatment for breast cancer: practical guide to survivorship care for family physicians. Can Family Phys. 2016;62:805–811.
   PubMed Web of Science ®Google Scholar
• Epplein M, Zheng Y, Zheng W, et al. Quality of life after breast cancer diagnosis and survival. J Clin oncol. 2011;29:406. doi:10.1200/JCO.2010.30.6951
   PubMed Web of Science ®Google Scholar
• De Aguiar SS, Bergmann A, Mattos IE. Quality of life as a predictor of overall survival after breast cancer treatment. Qual Life Res. 2014;23(2):627–637. doi:10.1007/s11136-013-0476-8
   PubMed Web of Science ®Google Scholar
• Chen LH, Irwin MR, Olmstead R, Haque R. Association of physical activity with risk of mortality among breast cancer survivors. JAMA Network Open. 2022;5:e2242660–e2242660. doi:10.1001/jamanetworkopen.2022.42660
   PubMedGoogle Scholar
• Saad ED, Katz A, Hoff PM, Buyse M. Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literature. Ann Oncol. 2010;21:7–12. doi:10.1093/annonc/mdp523
   PubMed Web of Science ®Google Scholar
• Zeichner SB, Koru-Sengul T, Shah N, et al. Improved clinical outcomes associated with vitamin d supplementation during adjuvant chemotherapy in patients With HER2+ nonmetastatic breast cancer. Clin Br Can. 2015;15:e1–e11. doi:10.1016/j.clbc.2014.08.001
   PubMedGoogle Scholar
• Diniz RW, Guerra MR, Cintra JRD, Fayer VA, Teixeira MTB. Disease-Free Survival In Patients With Non-Metastatic Breast Cancer. Rev Assoc Med Bras. 2016;62:407–413. doi:10.1590/1806-9282.62.05.407
   PubMed Web of Science ®Google Scholar
• Bhardwaj PV, Mason H, Kaufman SA, Visintainer P, Makari-Judson G. Outcomes of a multidisciplinary team in the management of patients with early-stage breast cancer undergoing neoadjuvant chemotherapy at a community cancer center. Current Oncol. 2023;30:4861–4870. doi:10.3390/curroncol30050366
   PubMed Web of Science ®Google Scholar
• Lu J, Jiang Y, Qian M, Lv L, Ying X. The improved effects Of A multidisciplinary team on the survival of breast cancer patients: experiences from China. Int J Environ Res Public Health. 2020;17:277. doi:10.3390/ijerph17010277
   Web of Science ®Google Scholar
• Niederhuber J, Armitage J, Doroshow J, Kastan M, Tepper J. Abeloff’s Clinical Oncology. 6th ed. Elsevier; 2020.
   Google Scholar
• Chan CWH, Law BMH, So WKW, Chow KM, Waye MMY. Novel strategies on personalized medicine for breast cancer treatment: an update. Int J Mol Sci. 2017;18:2423. doi:10.3390/ijms18112423
   PubMed Web of Science ®Google Scholar
• Hamer J, Warner E. Lifestyle modifications for patients with breast cancer to improve prognosis and optimize overall health. Cmaj. 2017;189:E268–E274. doi:10.1503/cmaj.160464
   PubMed Web of Science ®Google Scholar
• Neuss MN, Desch CE, McNiff KK, et al. A process for measuring the quality of cancer care: the quality oncology practice initiative. J Clin Oncol. 2005;23:6233–6239. doi:10.1200/JCO.2005.05.948
   PubMed Web of Science ®Google Scholar
• Fayanju O, Mayo TL, Spinks TE, et al. Value-based breast cancer care: a multidisciplinary approach for defining patient-centered outcomes. Ann Surg Oncol. 2016;23:2385–2390. doi:10.1245/s10434-016-5184-5
   PubMed Web of Science ®Google Scholar
• Ebben RH, Vloet L, Verhofstad MH, Meijer S, Groot JA, van Achterberg T. Adherence to guidelines and protocols in the prehospital and emergency care setting: a systematic review. Scand J Trauma Resusc Emerg Med. 2013;21:1–16. doi:10.1186/1757-7241-21-9
   PubMed Web of Science ®Google Scholar
• Hung DY. lean practices for resource use, timeliness, and coordination of care in breast cancer navigation. Number 5. 2022;26:503–509.
   Google Scholar
• Cottu P, Ramsey SD, Sola-Morales O, Spears PA, Taylor L. The emerging role of real-world data in advanced breast cancer therapy: recommendations for collaborative decision-making. Breast. 2022;61:118–122. doi:10.1016/j.breast.2021.12.015
   PubMed Web of Science ®Google Scholar
• Pfob A, Mehrara BJ, Nelson JA, Wilkins EG, Pusic AL, Sidey-Gibbons C. Towards patient-centered decision-making in breast cancer surgery: machine learning to predict individual patient-reported outcomes at 1-year follow-up. Ann Surg. 2023;277:e144. doi:10.1097/SLA.0000000000004862
   PubMed Web of Science ®Google Scholar
• Basile LJ, Carbonara N, Pellegrino R, Panniello U. Business intelligence in the healthcare industry: the utilization of a data-driven approach to support clinical decision making. Technovation. 2023;120:102482. doi:10.1016/j.technovation.2022.102482
   Web of Science ®Google Scholar
• Avril N, Sassen S, Roylance R. Response to therapy in breast cancer. J Nucl Med. 2009;50:55S–63S. doi:10.2967/jnumed.108.057240
   PubMedGoogle Scholar
• Cancer.net. Breast cancer: types of treatment; 2022. Available from: https://www.cancer.net/cancer-types/breast-cancer/types-treatment. Accessed August 7, 2023.
   Google Scholar
• Jayaraman M, Shanmugavadivu P, Riyaz NK. Multimodal data-driven intelligent systems for breast cancer prediction–a review. Eur Chem Bull. 2023;12:4349–4357.
   Google Scholar
• Amethiya Y, Pipariya P, Patel S, Shah M. Comparative analysis of breast cancer detection using machine learning and biosensors. Intel Med. 2022;2:69–81. doi:10.1016/j.imed.2021.08.004
   Google Scholar
• Baughan N, Douglas L, Giger MLP. Present, and future of machine learning and artificial intelligence for breast cancer screening. J Br Imag. 2022;4:451–459. doi:10.1093/jbi/wbac052
   PubMedGoogle Scholar
• Munro AJ, Swartzman S. What Is A virtual multidisciplinary team (vMDT)? Br J Cancer. 2013;108:2433–2441. doi:10.1038/bjc.2013.231
   PubMed Web of Science ®Google Scholar
• Nemade V, Pathak S, Dubey AK. A systematic literature review of breast cancer diagnosis using machine intelligence techniques. Arch. Comput. Methods Eng. 2022;29:4401–4430. doi:10.1007/s11831-022-09738-3
   Web of Science ®Google Scholar
• Chowdhary CL, Khare N, Patel H, Koppu S, Kaluri R, Rajput DSP. Present and future of gene feature selection for breast cancer classification–a survey. Internat J Engin Syst Mod Simul. 2022;13:140–153. doi:10.1504/IJESMS.2022.123355
   Web of Science ®Google Scholar
• Van Baelen K, Geukens T, Maetens M, et al. Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer. Ann Oncol. 2022;33:769–785. doi:10.1016/j.annonc.2022.05.006
   PubMedGoogle Scholar
• Cancer Research UK. Achieving world-class cancer outcomes; 2015. Available from: https://www.cancerresearchuk.org/sites/default/files/achieving_world-class_cancer_outcomes_-_a_strategy_for_england_2015-2020.pdf. Accessed July 20, 2023.
   Google Scholar
• Blackwood O, Deb R. Multidisciplinary team approach in breast cancer care: benefits and challenges. Indian J Pathol Microbiol. 2020;63:105. doi:10.4103/IJPM.IJPM_885_19
   Web of Science ®Google Scholar
• Scaggion A, Fusella M, Agnello G, et al. Limiting treatment plan complexity by applying a novel commercial tool. J Appl Clin Med Phys. 2020;21:27–34. doi:10.1002/acm2.12908
   PubMed Web of Science ®Google Scholar
• Lenti MV, Sottotetti F, Corazza GR. Tackling the clinical complexity of breast cancer. Drugs in Context. 2022;11. doi:10.7573/dic.2022-2-3
   PubMedGoogle Scholar
• Kimbung S, Loman N, Hedenfalk I. Clinical And Molecular Complexity Of Breast Cancer Metastases. Semi Cancer Biol. 2015;35:85–95.
   PubMed Web of Science ®Google Scholar
• Sumpio C, Knobf MT, Jeon S. Treatment complexity: a description of chemotherapy and supportive care treatment visits in patients with advanced-stage cancer diagnoses. Support Care Cancer. 2016;24:285–293. doi:10.1007/s00520-015-2775-9
   PubMed Web of Science ®Google Scholar
• Pan American Health Organization (PAHO). Planning: improving access to breast cancer care; 2016. Available from: https://www.paho.org/en/documents/planning-improving-access-breast-cancer-cure. Accessed July 20, 2023.
   Google Scholar
• Dobkowski D. The complexity of decision-making for early-stage breast cancer treatment; 2021. Available from: https://www.curetoday.com/view/the-complexity-of-decision-making-for-early-stage-breast-cancer-treatment. Accessed July 8, 2023.
   Google Scholar
• American Society of Clinical Oncology (ASCO). ASCO Guidelines; 2023. Available from: https://old-prod.asco.org/practice-patients/guidelines. Accessed August 15, 2023.).
   Google Scholar
• National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology; 2021. Available from: https://www.nccn.org/guidelines/guidelines-process/about-nccn-clinical-practice-guidelines. Accessed August 15, 2023.
   Google Scholar
• Van Eenbergen MC, Van de Poll-Franse LV, Heine P, Mols F. The impact of participation in online cancer communities on patient reported outcomes: systematic review. JMIR Cancer. 2017;3:e7312. doi:10.2196/cancer.7312
   Google Scholar
• Guan M, Han JY, Shah DV, Gustafson DH. Exploring the role of social support in promoting patient participation in health care among women with breast cancer. Health Communication. 2021;36:1581–1589. doi:10.1080/10410236.2020.1773704
   PubMed Web of Science ®Google Scholar
• Conner K. Treatment side effects depression; 2023. Available from: https://www.breastcancer.org/treatment-side-effects/depression. Accessed August 9, 2023.
   Google Scholar
• Feng Y, Spezia M, Huang S, et al. Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 2018;5:77–106.
   PubMed Web of Science ®Google Scholar
• Rankin NM, Lai M, Miller D, et al. Cancer multidisciplinary team meetings in practice: results from a multi‐institutional quantitative survey and implications for policy change. Asia Pacific J Clin Oncol. 2018;14:74–83. doi:10.1111/ajco.12765
   PubMed Web of Science ®Google Scholar
• Haq R, Kong A, Gulasingam P. A multidisciplinary approach to implement personalized breast cancer treatment and care plans. Current Oncol. 2021;28:767–782.
   PubMed Web of Science ®Google Scholar
• Lee PY, Cheong AT, Ghazali SS, et al. Barriers of and strategies for shared decision-making implementation in the care of metastatic breast cancer: a qualitative study among patients and healthcare professionals in an Asian country. Health Expect. 2022;25:2837–2850. doi:10.1111/hex.13590
   PubMed Web of Science ®Google Scholar
• Gravel K, Légaré F, Graham ID. Barriers and facilitators to implementing shared decision-making in clinical practice: a systematic review of health professionals’ perceptions. Implementation Sci. 2006;1:16.
   PubMed Web of Science ®Google Scholar
• Taberna M, Gil Moncayo F, Jane-Salas E, Antonio M, Arribas L, Vilajosana E. The multidisciplinary team (MDT) approach and quality of care. Front Oncol. 2020;10. doi:10.3389/fonc.2020.00085
   PubMed Web of Science ®Google Scholar
• Selby P, Popescu R, Lawler M, Butcher H, Costa A. The value and future developments of multidisciplinary team cancer care. Am Soc Clin Oncol Educat Book. 2019;39:332–340. doi:10.1200/EDBK_236857
   PubMedGoogle Scholar
• Cancer Research UK. Improving the effectiveness of multidisciplinary team meetings in cancer services; 2017. Available from: https://www.cancerresearchuk.org/about-us/we-develop-policy/our-policy-on-cancer-services/improving-The-effectiveness-of-mdts-in-cancer-services. Accessed August 15, 2023.
   Google Scholar
• Gandamihardja TAK, Soukup T, McInerney S, Green JSA, Sevdalis N. Analysing breast cancer multidisciplinary patient management: a prospective observational evaluation of team clinical decision-making. World J Surg. 2019;43:559–566. doi:10.1007/s00268-018-4815-3
   PubMed Web of Science ®Google Scholar
• Cancer Australia. All About Multidisciplinary Care; 2023. Available from: https://www.canceraustralia.gov.au/clinicians-hub/multidisciplinary-care/all-about-multidisciplinary-care. Accessed August 15, 2023.
   Google Scholar
• Lamb BW, Sevdalis N, Vincent C, Green JS. Development and evaluation of a checklist to support decision making in cancer multidisciplinary team meetings: MDT-quic. Ann Surg Oncol. 2012;19:1759–1765. doi:10.1245/s10434-011-2187-0
   PubMed Web of Science ®Google Scholar
• McCain DV. Facilitation Basics. Alexandria, USA: The Association for Talent Development; 2015.
   Google Scholar
• Odeh Y, Al-Balas M. Implications of agile values in software engineering for agility in breast cancer treatment: protocol for a comparative study. JMIR Res Prot. 2023;12:e53124. doi:10.2196/53124
   PubMed Web of Science ®Google Scholar
• Alzyadat W, Muhairat M, Alhroob A, Rawashdeh T. A recruitment big data approach to interplay of the target drugs. Internat J Adv Soft Comput. 2022;14:02–13. doi:10.15849/ZUJIJASACA.220328.01
   Google Scholar
• Abdallah M, Salah M. Artificial Intelligence and Intellectual properties: legal and ethical considerations. Int J Intell Syst and Appl Eng. 2024;12:368–376.
   Google Scholar